Equities

China Feihe Ltd

China Feihe Ltd

Actions
  • Price (HKD)5.38
  • Today's Change-0.24 / -4.27%
  • Shares traded11.97m
  • 1 Year change+12.79%
  • Beta--
Data delayed at least 15 minutes, as of Nov 22 2024 05:53 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

China Feihe Ltd is an investment holding company principally engaged in the production and sale of dairy products and raw milk, and sale of nutritional supplements. The Company primarily operates its businesses through two segments. Raw Milk segment is mainly engaged in the manufacture and sale of raw milk. Dairy Products and Nutritional Supplements Products segment is mainly engaged in the manufacture and sale of dairy products and sale of nutritional supplements. The Company's main products include infant milk formula products, adult milk powder, liquid milk, rice powder supplement products and other products. The Company distributes its products within the domestic market and to overseas markets.

  • Revenue in HKD (TTM)21.39bn
  • Net income in HKD3.84bn
  • Incorporated2012
  • Employees9.44k
  • Location
    China Feihe LtdStar City International BuildingC-16th Floor, 10 Jiuxianqiao RoadChaoyang DistrictBEIJING ChinaCHN
  • Websitehttps://www.feihe.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.